Bulletin
Investor Alert

Sage Therapeutics Inc.

NAS: SAGE

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200179567/composite

$

76.95

Change

-0.03 -0.04%

Volume

Volume 10,938

Mar 5, 2021, 5:28 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200179567/composite

Previous close

$ 70.65

$ 76.98

Change

+6.33 +8.96%

Day low

Day high

$68.23

$77.17

Open
Open: 71.00

52 week low

52 week high

$25.01

$98.39

Open

Market cap

$4.49B

Average volume

508,891

P/E ratio

6.94

Rev. per Employee

$3.74M

EPS

11.09

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/sage

MarketWatch News on SAGE

  1. Sage Therapeutics downgraded to neutral from buy at Mizuho

    7:51 a.m. Feb. 26, 2021

    - Tomi Kilgore

  2. Biogen’s Alzheimer’s Drug Faces a Big Test

    9:57 a.m. Feb. 11, 2021

    - Barron's Online

  3. Sage Therapeutics downgraded to market perform at BMO Capital

    8:58 a.m. Jan. 22, 2021

    - Tomi Kilgore

  4. Stocks Close Higher on Stimulus Hopes, Manufacturing Data

    6:03 p.m. Dec. 1, 2020

    - Barron's Online

  5. Zoom Stock Falls as News From China Lifts the Dow.

    8:57 a.m. Dec. 1, 2020

    - Barron's Online

  6. Sage Therapeutics downgraded to market perform from outperform at Raymond James

    8:20 a.m. Dec. 1, 2020

    - Tomi Kilgore

  7. S&P 500, Nasdaq book record closes on Black Friday

    4:11 p.m. Nov. 27, 2020

    - Mark DeCambre

  8. S&P 500 and Nasdaq Close at Records as Tech Stocks Outperform

    1:32 p.m. Nov. 27, 2020

    - Barron's Online

  9. Sage Soars, AstraZeneca Slips and the Dow Gets a Black Friday Bump

    8:20 a.m. Nov. 27, 2020

    - Barron's Online

  10. Sage Therapeutics shares soar 10% premarket after resuming trade following halt

    8:03 a.m. Nov. 27, 2020

    - Ciara Linnane

  11. Sage Therapeutics shares halted premarket for the news

    7:32 a.m. Nov. 27, 2020

    - Ciara Linnane

  12. Biogen and Sage Therapeutics to jointly develop therapies for depression and movement disorders

    7:31 a.m. Nov. 27, 2020

    - Ciara Linnane

  13. Sage Therapeutics to receive $1.525 bln in cash from Biogen as part of deal

    7:32 a.m. Nov. 27, 2020

    - Ciara Linnane

  14. Sage Therapeutics stock price target raised to $77 from $53 at Mizuho

    6:34 a.m. Nov. 6, 2020

    - Tomi Kilgore

  15. Sage Therapeutics upgraded to outperform from neutral at Wedbush

    6:08 a.m. Sept. 11, 2020

    - Tomi Kilgore

  16. Sage Therapeutics downgraded to neutral from outperform at Wedbush

    6:35 a.m. May 8, 2020

    - Tomi Kilgore

  17. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/sage

Other News on SAGE

  1. Premarket analyst action - healthcare

    9:27 a.m. Feb. 26, 2021

    - Seeking Alpha

  2. Why Did Mizuho Securities Downgrade SAGE Therapeutics’ Stock?

    4:15 a.m. Feb. 26, 2021

    - SmarterAnalyst

  3. Sage Therapeutics: Steady Recovery After Biogen Deal

    3:48 p.m. Feb. 25, 2021

    - Seeking Alpha

  4. 10-K: SAGE THERAPEUTICS, INC.

    7:19 a.m. Feb. 24, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  5. Sage Therapeutics EPS of $18.19

    6:36 a.m. Feb. 24, 2021

    - Seeking Alpha

  6. Notable earnings before Wednesday's open

    11:45 a.m. Feb. 23, 2021

    - Seeking Alpha

  7. Sage Therapeutics Q4 2020 Earnings Preview

    11:21 a.m. Feb. 23, 2021

    - Seeking Alpha

  8. Can Biogen (BIIB) Keep the Earnings Streak Alive in Q4?

    9:40 a.m. Feb. 1, 2021

    - Zacks.com

  9. Biogen upgraded to buy at Stifel on aducanumab optimism

    10:51 a.m. Jan. 29, 2021

    - Seeking Alpha

  10. Fundsmith Equity Fund Annual Letter 2020 To Shareholders

    9:50 a.m. Jan. 29, 2021

    - Seeking Alpha

  11. Sage Therapeutics downgraded at BMO citing valuation

    7:55 a.m. Jan. 22, 2021

    - Seeking Alpha

  12. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/sage

Press Releases on SAGE

  1. Sage Therapeutics to Present at Upcoming Investor Conferences

    5:00 p.m. Feb. 11, 2021

    - BusinessWire - BZX

  2. Sage Therapeutics Announces the Appointment of Barry Greene as CEO

    6:30 a.m. Dec. 16, 2020

    - BusinessWire - BZX

  3. The Biotech Breakthrough Transforming Mental Health

    9:02 a.m. Dec. 1, 2020

    - Financial News Media

  4. The Biotech Breakthrough Transforming Mental Health

    9:01 a.m. Dec. 1, 2020

    - PR Newswire - PRF

  5. Savvy Companies Making Moves in Drug-Development Space

    9:00 a.m. Nov. 12, 2020

    - NetworkNewsWire

  6. Savvy Companies Making Moves in Drug-Development Space

    8:30 a.m. Nov. 12, 2020

    - PR Newswire - PRF

  7. Sage Therapeutics Appoints Barry Greene to Board of Directors

    6:00 a.m. Oct. 1, 2020

    - BusinessWire - BZX

  8. Loading more headlines...

Rates »

Link to MarketWatch's Slice.